| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/09/2000 | EP0977841A2 Materials and methods for ribozyme treatment of retinal diseases |
| 02/09/2000 | EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 02/09/2000 | EP0977751A1 Somatostatin agonists |
| 02/09/2000 | EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977741A1 Substituted phenyl derivatives, their preparation and use |
| 02/09/2000 | EP0977575A1 THE USE OF $g(a)-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES |
| 02/09/2000 | EP0977569A1 Pharmaceutical composition for supressing type 2 helper t cell immune response |
| 02/09/2000 | EP0977568A1 Benzocycloheptathiophene compounds |
| 02/09/2000 | EP0977565A1 Pharmaceutical composition |
| 02/09/2000 | CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 02/08/2000 | US6022969 Symmetrical bis(aminoalkyl), bis(amidinoalkyl) and bis(guanidinoalkyl) cycloalkanes |
| 02/08/2000 | US6022898 Metalloproteinase inhibitors |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022546 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005260A1 Peptide analogues of pacap |
| 02/03/2000 | WO2000005245A2 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000005232A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/03/2000 | WO2000004899A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | WO2000004898A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999061444A3 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/03/2000 | WO1999059620A9 Angiostatin receptor |
| 02/03/2000 | CA2338524A1 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | CA2338299A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | CA2337399A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | CA2337349A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | CA2337247A1 Isquinolines as urokinase inhibitors |
| 02/03/2000 | CA2335341A1 Peptide analogues of pacap |
| 02/02/2000 | EP0976407A1 Antiseptic composition |
| 02/02/2000 | EP0975636A1 Novel compounds |
| 02/02/2000 | EP0975350A1 Use of an extract of alchemilli vulgaris |
| 02/02/2000 | CN1243507A Bis-sulfonomides hydroxamic acids as MMP inhibitors |
| 02/02/2000 | CN1048986C Heterocyclic compounds and their preparation and use |
| 02/01/2000 | US6020352 Treatment of ischemic disorders of the retina and optic nerve head |
| 02/01/2000 | US6020349 Constrained somatostatin agonists and antagonists |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 01/27/2000 | WO2000004010A1 Bicyclohexane derivatives |
| 01/27/2000 | WO2000003997A1 Thiobenzimidazole derivatives |
| 01/27/2000 | WO2000003741A2 Methods for reducing intraocular pressure using a3-adenosine antagonists |
| 01/27/2000 | WO2000003726A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | WO2000003710A1 Oxazolidinones to treat eye infections |
| 01/27/2000 | WO2000003705A1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999061406A3 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 01/27/2000 | WO1999017780A8 Dexamethasone gel |
| 01/27/2000 | CA2338054A1 Bicyclohexane derivatives |
| 01/27/2000 | CA2337499A1 Methods for reducing intraocular pressure using a3-adenosine antagonists |
| 01/27/2000 | CA2337231A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | CA2334811A1 Oxazolidinones to treat eye infections |
| 01/26/2000 | EP0973872A1 Use of nerve growth factor for the storage, culture or treatment of cornea |
| 01/26/2000 | EP0973804A2 Anti-vegf antibodies |
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973733A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973514A1 $i(IN VIVO) POLYMERIZABLE OPHTHALMIC COMPOSITIONS |
| 01/26/2000 | EP0973500A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0763016B1 Compositions and methods for treating mast-cell mediated conditions |
| 01/25/2000 | US6017889 Metalloproteinase inhibitors |
| 01/25/2000 | US6017768 For screening agonists or antagonists of alpha adrenergic receptors, dopamine receptors, sigma opiate receptors, potassium ion channels, carbonic anhydrase inhibitors; for treatment of glaucoma |
| 01/25/2000 | US6017728 ribH |
| 01/20/2000 | WO2000002904A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 01/20/2000 | WO2000002871A1 Novel angiogenesis inhibitors |
| 01/20/2000 | WO2000002571A1 Method of preparation and pharmaceutical composition of an uncaria water soluble extract |
| 01/20/2000 | WO2000002564A1 Prophylactic treatments of neovascularisation in macular degeneration |
| 01/20/2000 | WO2000002554A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | WO2000002543A2 Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/20/2000 | WO1999048858A3 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 01/20/2000 | CA2336990A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | CA2336848A1 Novel angiogenesis inhibitors |
| 01/20/2000 | CA2336703A1 Prophylactic treatments of neovascularisation in macular degeneration |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0971959A1 Humanized antibodies and methods for forming humanized antibodies |
| 01/19/2000 | EP0971887A1 Metalloproteinase inhibitors |
| 01/19/2000 | EP0971885A1 Process for preparing indane-like compounds |
| 01/19/2000 | EP0859751B1 Semi-fluorinated alkanes and their use |
| 01/19/2000 | EP0696917B1 Method for inhibiting posterior capsule opacification |
| 01/19/2000 | CN1242006A Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1242001A Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1241997A Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 01/19/2000 | CN1241558A Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology |
| 01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015818 Quinoline derivatives as bradykinin agonists |
| 01/18/2000 | US6015810 Aqueous ophthalmic solution containing apafant as active ingredient |
| 01/18/2000 | US6015712 Antisense modulation of FADD expression |
| 01/18/2000 | US6015569 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/14/2000 | WO2000003736A1 Prostaglandin product |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/13/2000 | WO2000001702A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001701A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001395A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/13/2000 | WO2000001382A1 Inhibitors of prenyl-protein transferase |